Pneumothorax and Pneumomediastinum in COVID-19 Suggest a Pneumocystic Pathology.

ABSTRACT:

Objective

To determine whether the apparent excess incidence of pneumothorax and pneumomediastinum in patients with coronavirus disease 2019 (COVID-19) is explained adequately by iatrogenic causes vs reflecting sequelae of severe acute respiratory syndrome coronavirus 2 infection.

Patients and methods

We retrospectively reviewed patients within our health care system from March 15, 2020, through May 31, 2020, who had a diagnosis of pneumothorax or pneumomediastinum during hospitalization for confirmed COVID-19 infection with attention to timing of pneumothorax and pneumomediastinum; presence, laterality, and placement, or attempts at central lines; and presence of mechanical ventilation before the event.

Results

We report clinical data and outcomes from 9 hospitalized

SUBMITTER: Jamil AK 

PROVIDER: S-EPMC8385307 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature